These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16248462)

  • 1. [Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Wei J; Huang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):643-5. PubMed ID: 16248462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression of proliferating cell nuclear antigen and Bcl-2 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Huang X; Wang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Apr; 17(4):217-9. PubMed ID: 12838865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bcl-2, p53 expression and Epstein-Barr virus infection in primary nasopharyngeal carcinoma].
    Cheng Q; Liu G; Wu Z; Wu Y; Xiao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):455-7. PubMed ID: 12541691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
    Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
    Zhou Y; Xu A; Ling X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of p53, proliferating cell nuclear antigen, and Ki-67 expression in undifferentiated nasopharyngeal carcinomas.
    Genç E; Hoşal AS; Gedikoğlu G; Ozyar E; Sözeri B
    Otolaryngol Head Neck Surg; 2000 Jun; 122(6):868-73. PubMed ID: 10828801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
    Luo HN; Li XP; Liu X; Zhang GH; Liu YL
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of human nuclear distribution C in nasopharyngeal carcinoma].
    Chen Y; Yang Y; Lin Z; Peng H; Lu H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):71-3. PubMed ID: 21473139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].
    Cui D; Zhang X; Fu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 22(15):692-4. PubMed ID: 18950008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and significance of p53 and proliferating cell nuclear antigen in malignant tumor of maxillary sinus].
    Xie RH; Chen ZH; Chen MY; Hou JH; Wu JH; Wu GH; Wu QL
    Ai Zheng; 2002 Nov; 21(11):1244-7. PubMed ID: 12526226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
    Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P
    Anticancer Res; 1997; 17(4A):2615-9. PubMed ID: 9252690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of AIB1 in nasopharyngeal carcinomas correlates closely with advanced tumor stage.
    Liu MZ; Xie D; Mai SJ; Tong ZT; Shao JY; Fu YS; Xia WJ; Kung HF; Guan XY; Zeng YX
    Am J Clin Pathol; 2008 May; 129(5):728-34. PubMed ID: 18426732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.